Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: A cohort study

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Seneviratne, Sanjeewa ^a,b   Campbell, Ian ^a   Scott, Nina ^c   Kuper Hommel, Marion ^c   Round, Glenys ^c   Lawrenson, Ross ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF COLOMBO   (Sri Lanka)

^c WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Breast cancer; Chemotherapy; Delay; Ethnicity; Inequity; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; EUROPEAN; FEMALE; HUMAN; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MAORI (PEOPLE); NEW ZEALAND; POPULATION RESEARCH; PRIVATE HOSPITAL; PROSPECTIVE STUDY; REOPERATION; RURAL POPULATION; SEX RATIO; THERAPY DELAY; TUMOR INVASION; URBAN POPULATION; VERY ELDERLY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ANIMAL; BREAST NEOPLASMS; CANCER STAGING; ETHNIC GROUP; ETHNOLOGY; HEALTH SURVEY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; REGISTER; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; ETHNIC GROUPS; FEMALE; HUMANS; MIDDLE AGED; MORTALITY; NEOPLASM STAGING; NEW ZEALAND; POPULATION SURVEILLANCE; RADIOTHERAPY, ADJUVANT; REGISTRIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84965090364     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-839     Document Type: Article

References (42)

1. Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA: Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 2006, 24(9):1357-1362.
2. Griggs JJ, Culakova E, Sorbero ME, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH: Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. J Clin Oncol 2007, 25(18):2522-2527.
3. Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, Brinton LA, Eley JW, Coates RJ: Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 2004, 100(8):1595-1604.
4. Lund MJ, Brawley OP, Ward KC, Young JL, Gabram SS, Eley JW: Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat 2008, 109(3):545-557.
5. Fedewa SA, Ward EM, Stewart AK, Edge SB: Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol 2010, 28(27):4135-4141.
6. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ: Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999, 353(9159):1119-1126.
7. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI: Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat 2006, 99(3):313-321.
8. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI: Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 2006, 65(5):1353-1360.
9. Gagliato Dde M, Gonzalez-Angulo AM, Lei X, Theriault RL, Giordano SH, Valero V, Hortobagyi GN, Chavez-Macgregor M: Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol 2014, 32(8):735-744.
10. Robson B, Purdie G, Cormack D: Unequal impact II: Maori and Non-Maori cancer statistics by deprivation and rural-urban status 2002-2006. Ministry of Health: Wellington; 2010.
11. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353(17):1784-1792.
12. Biagi JJ, Raphael M, King WD, Kong W, Booth CM, Mackillop WJ: The effect of delay in time to adjuvant chemotherapy (TTAC) on survival in breast cancer (BC): a systematic review and meta-analysis. J Clin Oncol 2011, 29(No 15_suppl, 2011 ASCO Annual Meeting Abstracts):1128.
13. Yu KD, Huang S, Zhang JX, Liu GY, Shao ZM: Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis. BMC Cancer 2013, 13:240.
14. Seneviratne S, Campbell I, Scott N, Coles C, Lawrenson R: Treatment delay for Maori women with breast cancer in New Zealand. Ethnicity & health 2014:1-16. ahead-of-print.
15. Stevens W, Stevens G, Kolbe J, Cox B: Ethnic differences in the management of lung cancer in New Zealand. J Thorac Oncol 2008, 3(3):237-244.
16. Hill S, Sarfati D, Blakely T, Robson B, Purdie G, Dennett E, Cormack D, Dew K, Ayanian JZ, Kawachi I: Ethnicity and management of colon cancer in New Zealand: do indigenous patients get a worse deal? Cancer 2010, 116(13):3205-3214.
17. Seneviratne S, Campbell I, Scott N, Shirley R, Peni T, Lawrenson R: Accuracy and completeness of the New Zealand Cancer Registry for staging of invasive breast cancer. Cancer Epidemiol 2014, 38(5):638-644.
18. AJCC: Cancer Staging Manual. 7th edition. New York: Springer-Verlag; 2010.
19. Salmond C, Crampton P, Atkinson J: NZDep2006: Index of Deprivation. In Department of Public Health, University of Otago, Wellington. Ministry of Health; 2007.
20. New Zealand: an urban/rural profile. http://www.stats.govt.nz/browse_for_stats/people_and_communities/Geographic-areas/urban-rural-profile.aspx.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
22. Freedman RA, He Y, Winer EP, Keating NL: Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care? Health Serv Res 2013, 48(5):1669-1683.
23. Lohrisch C, Paltiel C, Gelmon K, Speers C, Taylor S, Barnett J, Olivotto IA: Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 2006, 24(30):4888-4894.
24. Colleoni M, Bonetti M, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner J, Collins J, Thurlimann B, Holmberg S, Veronesi A, Marini G, Goldhirsch A: Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol 2000, 18(3):584-590.
25. McLaughlin JM, Anderson RT, Ferketich AK, Seiber EE, Balkrishnan R, Paskett ED: Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol 2012, 30(36):4493-4500.
26. McKenzie F, Ellison-Loschmann L, Jeffreys M: Investigating reasons for ethnic inequalities in breast cancer survival in New Zealand. Ethn Health 2011, 16(6):535-549.
27. Guidry JJ, Aday LA, Zhang D, Winn RJ: Transportation as a barrier to cancer treatment. Cancer Pract 1997, 5(6):361-366.
28. Nelson AR: Unequal treatment: report of the Institute of Medicine on racial and ethnic disparities in healthcare. Ann Thorac Surg 2003, 76(4):S1377-1381.
29. Merrill R, Merrill A, Mayer L: Factors associated with no surgery or radiation therapy for invasive cervical cancer in Black and White women. Ethnicity Dis 1999, 10(2):248-256.
30. Mundt AJ, Connell PP, Campbell T, Hwang JH, Rotmensch J, Waggoner S: Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol 1998, 71(2):151-158.
31. Tatau Kahukura: Maori Health Chart Book 2010. 2nd edition. Wellington: Ministry of Health; 2010.
32. Rippy EE, Ainsworth R, Sathananthan D, Kollias J, Bochner M, Whitfield R: Influences on decision for mastectomy in patients eligible for breast conserving surgery. Breast 2014, 23(3):273-278.
33. Schwartz F, Evans W, Sullivan T, Angus H: Gaining access to appropriate cancer services: a four point strategy to reduce waiting times in Ontario. Canada: Cancer quality council of Ontario; 2004.
34. Garcia SF, Hahn EA, Jacobs EA: Addressing low literacy and health literacy in clinical oncology practice. J Supportive Oncol 2010, 8(2):64-69.
35. Woynar SP, Burban P, Le Prisé E, Romestaing P, Maylin C, Mazeau V, Cauterman M, Vendrely V: Reducing radiotherapy delays after surgery for breast cancer in five radiotherapy departments. J Clin Oncol 2007, 25:no. 18_suppl 17011.
36. Kallen MA, Terrell JA, Lewis-Patterson P, Hwang JP: Improving wait time for chemotherapy in an outpatient clinic at a comprehensive cancer center. J Oncol Pract /Am Soc Clin Oncol 2012, 8(1):e1-7.
37. Kenny L, Lehman M: Sequential audits of unacceptable delays in radiation therapy in Australia and New Zealand. Australas Radiol 2004, 48(1):29-34.
38. Whop LJ, Valery PC, Beesley VL, Moore SP, Lokuge K, Jacka C, Garvey G: Navigating the cancer journey: a review of patient navigator programs for Indigenous cancer patients. Asia Pac J Clin Oncol 2012, 8(4):e89-96.
39. Collinson L, Foster RH, Stapleton M, Blakely T: Cancer care coordinators: what are they and what will they cost? N Z Med J 2013, 126(1381):75-86.
40. Hershman DL, Unger JM, Barlow WE, Hutchins LF, Martino S, Osborne CK, Livingston RB, Albain KS: Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol 2009, 27(13):2157-2162.
41. Griggs JJ, Culakova E, Sorbero ME, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH: Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol 2007, 25(3):277-284.
42. Salmond CE, Crampton P: Development of New Zealand's deprivation index (NZDep) and its uptake as a national policy tool. Can J Public Health 2012, 103(8 Suppl 2):S7-11.